IRGD Peptide (Highly Pure)

<strong>iRGD Peptide (Highly Pure)</strong>_x000D_ <strong>Catalog number:</strong> B2019017_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 948.04 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −80°C_x000D_ <strong>Keywords:</strong> 1392278-76-0|iRGD peptide|UNII-Z8MXU5GH4Q|iRGD|(6S,9S,15S,18R,23R,26S,29S)-18-amino-6-(4-aminobutyl)-9,26-bis(carboxymethyl)-15-[3-(diaminomethylideneamino)propyl]-2,5,8,11,14,17,25,28-octaoxo-20,21-dithia-1,4,7,10,13,16,24,27-octazabicyclo[27.3.0]dotriac_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kang S, Lee S, Park S. iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery Polymers (Basel). 2020 Aug 24;12(9):1906._x000D_ 2: Yin H, Yang J, Zhang Q, Yang J, Wang H, Xu J, Zheng J. iRGD as a tumor‑penetrating peptide for cancer therapy (Review) Mol Med Rep. 2017 May;15(5):2925-2930._x000D_ 3: Zuo H. iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers J Oncol. 2019 Jun 26;2019:9367845._x000D_ 4: Cho HJ, Park SJ, Lee YS, Kim S. Theranostic iRGD peptide containing cisplatin prodrug: Dual-cargo tumor penetration for improved imaging and therapy J Control Release. 2019 Apr 28;300:73-80._x000D_ 5: D'Amore VM, Donati G, Lenci E, Ludwig BS, Kossatz S, Baiula M, Trabocchi A, Kessler H, Di Leva FS, Marinelli L. Molecular View on the iRGD Peptide Binding Mechanism: Implications for Integrin Activity and Selectivity Profiles J Chem Inf Model. 2023 Oct 23;63(20):6302-6315._x000D_ 6: Li H, Shi S, Wu M, Shen W, Ren J, Mei Z, Ran H, Wang Z, Tian Y, Gao J, Zhao H. iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma Int J Nanomedicine. 2021 Sep 21;16:6455-6475._x000D_ 7: Paul B, Gaonkar RH, Dutta D, Dasi R, Mukherjee B, Ganguly S, Das SK. Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma Biomater Adv. 2022 Mar;134:112714._x000D_ 8: Song Y, Xu M, Li Y, Li Y, Gu W, Halimu G, Fu X, Zhang H, Zhang C. An iRGD peptide fused superantigen mutant induced tumor-targeting and T lymphocyte infiltrating in cancer immunotherapy Int J Pharm. 2020 Aug 30;586:119498._x000D_ 9: Chen B, Liu X, Li Y, Shan T, Bai L, Li C, Wang Y. iRGD Tumor-Penetrating Peptide-Modified Nano-Delivery System Based on a Marine Sulfated Polysaccharide for Enhanced Anti-Tumor Efficiency Against Breast Cancer Int J Nanomedicine. 2022 Feb 9;17:617-633._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/38843844">10: Pan Y, Xue Q, Yang Y, Shi T, Wang H, Song X, Luo Y, Liu W, Ren S, Cai Y, Nie Y, Song Z, Liu B, Li JP, Wei J. Glycoengineering-based anti-PD-1-iRGD peptide conjugate boosts antitumor efficacy through T cell engagement Cell Rep Med. 2024 Jun 18;5(6):101590. </a>_x000D_ _x000D_ <strong>Products Related to iRGD Peptide (Highly Pure) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>